NPI: 1669424354 · SILVERTON, OR 97381 · Clinic/Center · NPI assigned 05/17/2006
Authorized official JENSEN, SARAH controls 20+ related entities in our dataset. Read more
| Authorized Official | JENSEN, SARAH (CFO) |
| NPI Enumeration Date | 05/17/2006 |
Other providers sharing the same authorized official: JENSEN, SARAH
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 29,477 | $1.85M |
| 2019 | 33,179 | $2.07M |
| 2020 | 25,554 | $3.14M |
| 2021 | 33,273 | $3.84M |
| 2022 | 51,010 | $5.64M |
| 2023 | 50,280 | $6.49M |
| 2024 | 46,263 | $6.15M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 43,058 | 40,489 | $8.06M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 18,840 | 16,502 | $6.85M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 28,855 | 26,094 | $6.76M |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 1,186 | 1,127 | $953K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 7,498 | 7,147 | $831K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 27,444 | 25,381 | $791K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 3,016 | 2,829 | $632K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 8,558 | 7,858 | $516K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 11,801 | 10,920 | $500K |
| 80053 | Comprehensive metabolic panel | 20,109 | 18,607 | $410K |
| 84703 | 8,554 | 8,141 | $329K | |
| 83690 | 7,946 | 7,392 | $281K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 3,615 | 3,478 | $253K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 1,926 | 1,816 | $207K |
| 96375 | Therapeutic injection; each additional sequential IV push | 4,036 | 3,704 | $183K |
| 71046 | Radiologic examination, chest; 2 views | 6,007 | 5,589 | $165K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 1,979 | 1,854 | $154K |
| 96361 | Intravenous infusion, hydration; each additional hour | 2,707 | 2,384 | $131K |
| 81001 | 10,823 | 10,160 | $115K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 101 | 97 | $102K |
| J2704 | Injection, propofol, 10 mg | 3,249 | 3,014 | $91K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 794 | 774 | $58K |
| 81003 | 7,225 | 6,794 | $56K | |
| 84484 | 2,076 | 1,877 | $52K | |
| 87631 | 1,180 | 1,123 | $48K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 329 | 237 | $47K |
| 87081 | 1,158 | 1,103 | $44K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 3,669 | 3,383 | $44K |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 38 | 36 | $43K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | 102 | 98 | $42K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 6,856 | 5,745 | $38K |
| 36415 | Collection of venous blood by venipuncture | 4,762 | 4,252 | $37K |
| 83735 | 2,480 | 2,287 | $36K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 153 | 147 | $33K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 4,833 | 4,523 | $19K |
| 82947 | 1,832 | 1,694 | $17K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 608 | 581 | $17K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 515 | 183 | $15K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1,071 | 1,005 | $14K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 459 | 444 | $14K |
| 90834 | Psychotherapy, 45 minutes with patient | 140 | 79 | $13K |
| 81025 | 305 | 281 | $13K | |
| 90832 | Psychotherapy, 30 minutes with patient | 204 | 159 | $13K |
| 74018 | 188 | 184 | $12K | |
| C9113 | Injection, pantoprazole sodium, per vial | 544 | 508 | $11K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 98 | 72 | $10K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 80 | 80 | $10K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 55 | 51 | $9K |
| J1756 | Injection, iron sucrose, 1 mg | 71 | 36 | $8K |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 51 | 51 | $8K |
| 70450 | Computed tomography, head or brain; without contrast material | 96 | 89 | $7K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 54 | 52 | $6K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 649 | 604 | $6K |
| 83880 | 90 | 85 | $6K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 2,185 | 2,012 | $5K |
| J2470 | Injection, pantoprazole sodium, 40 mg | 79 | 75 | $5K |
| 99215 | Prolong outpt/office vis | 30 | 29 | $4K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 168 | 151 | $4K |
| 93976 | 13 | 13 | $4K | |
| 71045 | Radiologic examination, chest; single view | 84 | 82 | $4K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 79 | 72 | $3K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 76 | 72 | $3K |
| 85379 | 88 | 81 | $3K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 88 | 82 | $3K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 13 | 13 | $3K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 76 | 72 | $2K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 316 | 306 | $2K |
| J2270 | Injection, morphine sulfate, up to 10 mg | 67 | 63 | $2K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 32 | 28 | $2K |
| J0690 | Injection, cefazolin sodium, 500 mg | 42 | 40 | $1K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 183 | 176 | $1K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 62 | 62 | $1K |
| 87430 | 61 | 60 | $1K | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 93 | 91 | $1K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 188 | 167 | $1K |
| J0780 | Injection, prochlorperazine, up to 10 mg | 74 | 69 | $966.40 |
| 77063 | Screening digital breast tomosynthesis, bilateral | 80 | 80 | $897.02 |
| 90686 | 64 | 64 | $780.00 | |
| 36592 | 44 | 42 | $678.88 | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 12 | 12 | $665.42 |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 14 | 14 | $644.07 |
| 99442 | 19 | 18 | $606.48 | |
| 99441 | 49 | 47 | $573.30 | |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 16 | 15 | $490.67 |
| 86140 | 12 | 12 | $412.67 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 125 | 116 | $394.89 |
| A6257 | Transparent film, sterile, 16 sq. in. or less, each dressing | 70 | 39 | $386.43 |
| J1170 | Injection, hydromorphone, up to 4 mg | 17 | 17 | $302.15 |
| 83605 | 43 | 39 | $290.56 | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 27 | 24 | $164.74 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 44 | 39 | $113.52 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 152 | 80 | $98.85 |
| 96160 | 13 | 13 | $48.63 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 13 | 13 | $42.12 |
| 82150 | 14 | 14 | $5.60 | |
| 94799 | 14 | 14 | $0.00 | |
| 82553 | 12 | 12 | $0.00 | |
| 82550 | 12 | 12 | $0.00 |